BiomEdit

Private

Indianapolis, IndianaHealthcare & Life Scienceshttps://biomedit.com/

Last Round

Grant

Oct 24, 2025

Total Funding Raised

$103.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BiomEdit is a biotechnology company that develops a microbiome innovation platform to discover and create products that enhance animal protein production and improve livestock disease monitoring through microbiome-derived bioactive and engineered microbial medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Government Contracts

AI Layer

Foundation

Keywords

engineered probioticsanimal healthmethane reductionsynbiomicrobiomefeed additivesrumen digital twinagtechbiotechmethane mitigationfoundation modellivestock sustainabilitypredictive modelingbiological productsclimate tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BiomEdit Comps

Public and private peers based on sector, stage, and business model.

BiomEdit comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BiomEdit Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 24, 2025
Grant	Jul 16, 2025
Series B	Jul 15, 2025
Grant	Nov 1, 2023
Series A	Feb 18, 2023
Series A	Apr 11, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Aaron Schacht

Chief Executive Officer And Board Director

Executive Team

Eric Young

Chief Financial Officer And Chief Business Officer

Executive Team

J. Bruce Schelkopf

Chief Legal Officer (CLO) & Chief Administrative Officer (CAO), GC, Company Secretary, CIPO COO CCO

Executive Team

BiomEdit Investors

Notable investors and investment history

BiomEdit investors
Investor	Rounds
Elevate Ventures	Series B
NIH RADx	Grant
Anterra Capital	Series A, Series B
Bezos Earth Fund	Grant
The Bill & Melinda Gates Foundation Trust	Grant
Viking Global Investors	Series A
Global Methane Hub	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 23, 2025
Secured $2M in grant funding.
Jul 16, 2025
$1.7M grant from Global Methane Hub, NIH RADx, and USDA.

View all signals

BiomEdit Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BiomEdit Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BiomEdit's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana

Employee Range34

Year Founded2022

Last FundingOct 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.